Recombinant IL2RA (Daclizumab Biosimilar) 抗体
This anti-IL2RA (Daclizumab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting IL2RA (Daclizumab Biosimilar) in ELISA. Suitable for 人.
Quick Overview for Recombinant IL2RA (Daclizumab Biosimilar) 抗体 (ABIN7487796)
抗原
IL2RA (Daclizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This IL2RA (Daclizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Daclizumab Biosimilar - Anti-IL2RA mAb
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
anti-IL2RA (Daclizumab Biosimilar) antibody
适用: 人, Cynomolgus, 猕猴 FACS, BR 宿主: 兔 Chimeric unconjugated Recombinant Antibody
anti-IL2RA (Daclizumab Biosimilar) antibody适用: 人, Cynomolgus, 猕猴 FACS, BR 宿主: Human Monoclonal unconjugated Recombinant Antibody
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- IL2RA (Daclizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
BIIB019,DAC HYP
Daclizumab is a humanized IgG1 monoclonal antibody that binds to human interleukin 2 receptor (anti-Tac or anti-CD25)and composed of human >90%) and murine (10%) antibody sequences. The human sequence is derived from the constant domain of human IgG1 and the variable framework region of Eu myeloma antibody. The murine part was taken from the complementarity-determining regions of a murine anti-Tac antibody. Daclizumab has been used for preventing acute organ rejection in de novo allogeneic kidney transplantation when used simultaneously with immunosuppressive regimens such as cyclosporine and corticosteroid and in the treatment of adult patients with relapsing multiple sclerosis. These trademarks were Zenapax and Zimbryta, respectively. -
CAS-编号
- 152923-56-3
抗原
-
You are here:
